Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy.
BACKGROUND
Cardiac resynchronization therapy (CRT) is generally associated with a low to moderate increase of the left ventricular ejection fraction (LVEF). In some patients, however, LVEF improves remarkably and reaches near-normal values. The aim of the present study was to further characterize these so called 'super-responders' with a special focus on the extent of intra- and interventricular asynchrony before and after device implantation compared to average responders.


METHODS
37 consecutive patients who underwent CRT device implantation according to current guidelines were included in the study. Patients were examined by echocardiography before, one day after and six months after device implantation. Pre-defined criterion for superior response to CRT was an LVEF increase > 15% after six months.


RESULTS
At follow-up, eight patients (21.6%) were identified as super-responders. There were no significant differences regarding age, gender, prevalence of ischemic heart disease and LVEF between average and super-responders at baseline. After six months, LVEF had significantly increased from 26.7% ± 5.7% to 33.1% ± 7.9% (p < 0.001) in average and from 24.0% ± 6.7% to 50.3% ± 7.4% (p < 0.001) in super-responders. Both groups showed a significant reduction of QRS duration as well as LV end-diastolic and -systolic volumes under CRT. At baseline, the interventricular mechanical delay (IVMD) was 53.7 ± 20.9 ms in average and 56.9 ± 22.4 ms in super-responders - representing a similar extent of interventricular asynchrony in both groups (p = 0.713). CRT significantly reduced the IVMD to 20.3 ± 15.7 (p < 0.001) in average and to 19.8 ± 15.9 ms (p = 0.013) in super-responders with no difference between both groups (p = 0.858). As a marker for intraventricular asynchrony, we assessed the longest intraventricular delay between six basal LV segments. At baseline, there was no difference between average (86.2 ± 30.5 ms) and super-responders (78.8 ± 23.6 ms, p = 0.528). CRT significantly reduced the longest intraventricular delay in both groups--with a significant difference between average (66.2 ± 36.2 ms) and super-responders (32.5 ± 18.3 ms, p = 0.022). Multivariate logistic regression analysis identified the longest intraventricular delay one day after device implantation as an independent predictor of superior response to CRT (p = 0.038).


CONCLUSIONS
A significant reduction of the longest intraventricular delay correlates with superior response to CRT.
Dreger
Henryk
H
Medizinische Klinik für Kardiologie und Angiologie, Campus Mitte, Charité - Universitätsmedizin Berlin, Germany. henryk.dreger@charite.de
Borges
Adrian C
AC
Baumann
Gert
G
Melzer
Christoph
C
D000368:Aged; D058406:Cardiac Resynchronization Therapy / Q000379:methods*; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000000981:diagnostic imaging / Q000503:physiopathology*; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000294:innervation / Q000503:physiopathology*; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D013318:Stroke Volume / Q000502:physiology; D016896:Treatment Outcome; D020257:Ventricular Remodeling / Q000502:physiology*
Circulation. 2008 May 20;117(20):2608-16
18458170
J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
2698218
Eur Heart J. 2009 Oct;30(20):2470-7
19717847
Cardiovasc Ultrasound. 2009 Sep 25;7:46
19781060
N Engl J Med. 2004 May 20;350(21):2140-50
15152059
N Engl J Med. 2005 Apr 14;352(15):1539-49
15753115
J Am Coll Cardiol. 2002 Jul 3;40(1):111-8
12103264
N Engl J Med. 2002 Jun 13;346(24):1845-53
12063368
Eur Heart J. 2006 Jun;27(11):1270-81
16527827
Pacing Clin Electrophysiol. 2003 Jan;26(1P2):137-43
12687799
Heart Rhythm. 2010 Jul;7(7):885-9
20382271
Cardiovasc Ultrasound. 2008 Dec 31;6:65
19117517
JAMA. 2007 Jun 13;297(22):2502-14
17565085
Am J Cardiol. 2010 May 1;105(9):1327-35
20403487
Europace. 2009 Mar;11(3):343-9
19240109
Eur Heart J. 2007 Sep;28(18):2256-95
17726042